Editorial: The role of epigenetic modification in MDSC differentiation and function

Xinyu Tian; Lele Zhu; Jie Tian; Shengjun Wang

doi:10.3389/fimmu.2023.1177138

Editorial: The role of epigenetic modification in MDSC differentiation and function

Front Immunol. 2023 Mar 14:14:1177138. doi: 10.3389/fimmu.2023.1177138. eCollection 2023.

Authors

Xinyu Tian¹, Lele Zhu², Jie Tian³, Shengjun Wang^{3

4}

Affiliations

¹ Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
² Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
³ Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
⁴ Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.

No abstract available

Keywords: MDSCs (myeloid-derived suppressor cells); antitumor immune response; autoimmune; epigenetic modification; regulatory mechanism.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cell Line, Tumor
Epigenesis, Genetic
Myeloid-Derived Suppressor Cells*

Grants and funding

This work was supported by the National Natural Science Foundation of China (Grant No. 82272403), the Jiangsu Postdoctoral Research Foundation (Grant No. 2018K253C), and the China Postdoctoral Science Foundation (Grant No. 2018ZM642225).